Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Buzz on the Bullboards: Top Stocks Plan Moves for 2022

( Ore stockpiles at the Kakula North decline containing 2.04 million tonnes grading 5.13% copper as of December 31, 2021. Image via Ivanhoe Mines Ltd.) 2022 started off with a bang for investors as many sectors were rocked by the spread of the Omicron Coronavir...
Stockhouse Editorial | January 18, 2022 |

Marin Katusa Unfiltered: Warren Buffett Just Dropkicked the Resource Sector

The cost of capital for every single resource company changed on Tuesday, April 30 th , 2019. I’ve written extensively about the coming reality check for the resource sector. There is a significant amount of debt coming due. Management teams are preten...
Marin Katusa | May 3, 2019 |

G20 News Drive Big Moves In The Markets

This past weekend was full of exciting news and information. Combine this with the strong US economic activity, the potential for some type of reprieve in the US/China trade issues and the historic meeting in North Korea between President Trump and Kim Jun Un, and the market...
Chris Vermeulen | July 3, 2019 |

Bulls Beware: A Dark Cloud Is Forming Over Oil Markets

Bullish sentiment appears to have returned to the stock markets with a vengeance. In a historic rally that has taken even die-hard bulls by surprise, the S&P 500 has managed to claw back all of its 2020 losses, taking just 53 sessions for the index to fully restore the nearl...
Alex Kimani | June 12, 2020 |

Buzz on the Bullboards: Top Names in Mining, Cannabis, & Industrial Stocks

Having received UL 2723 ECOLOGO Certification for Mineral Exploration Companies last week, Critical Elements Lithium Corporation ( TSX-V: CRE , Forum ) announced this week that it had retained the services of Metso Outotec and WSP in Canada (WSP) to prepare a Pha...
Stockhouse Editorial | June 10, 2021 |

Our Long-Anticipated Gold Momentum Rally Begins

Over the past 6+ months, we've been covering the price rotations in precious metals very closely. We've issued a number of amazing calls regarding Gold and Silver over the past few months. Two of the biggest calls we've made were the late 2018 research post that suggested Gold...
Chris Vermeulen | May 15, 2019 |

Could Gold Launch Into A Parabolic Upside Rally?

We believe Gold is setting up for an incredible upside breakout move after reaching our predicted target near $1450. For those of you that have been following our research and Gold calls, we've nailed this move and our October 2018 predictive modeling call has continued to mir...
Chris Vermeulen | July 12, 2019 |

Proteostasis Therapeutics Reports Positive Results from European Cystic Fibrosis Research

Proteostasis Therapeutics' shares traded higher today after the company reported positive results in its European Cystic Fibrosis study of organoids grown from human stem cells. The firm believes the ongoing ex-vivo study supports initiation of a human clinical trial in mid-20...
Streetwise Reports | December 12, 2019 |

Applied Genetic Tech's Shares Double on 6-Month X-Linked RP Study Results

Shares of Applied Genetic Technologies skyrocketed to a new 52-week high price after the company reported positive six-month data from its ongoing Phase 1/2 clinical study for treatment in X-Linked Retinitis Pigmentosa. The firm stated that the trial data suggests durable and ...
Streetwise Reports | January 10, 2020 |

Exelixis Shares Climb 21% on Positive Phase 3 Advanced Kidney Cancer Study Results

Shares of Exelixis reached a new 52-week high price after the firm reported positive topline results from its Pivotal Phase 3 CheckMate -9ER trial evaluating Opdivo® (nivolumab) in combination with CABOMETYX® (cabozantinib) in previously untreated advanced ...
Streetwise Reports | April 21, 2020 |
1 2 3 4